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Analysis of protein sequences by the informational spectrum method (ISM) enables
characterization of their specificity according to encoded information represented with
defined frequency (F). Our previous data showed that F(0.367) is characteristic for
variable heavy chain (VH) domains (a combination of variable (V), diversity (D) and
joining (J) gene segments) of the anti-phosphocholine (PC) T15 antibodies and mostly
dependent on the CDR2 region, a site for PC phosphate group binding. Because
the T15 dsDNA-reactive U4 mutant also encodes F(0.367), we hypothesized that the
same frequency may also be characteristic for anti-DNA antibodies. Data obtained from
an analysis of 60 spontaneously produced anti-DNA antibody VH domain sequences
supported our hypothesis only for antibodies, which use V gene segment in germline
configuration, such as S57(VH31), MRL-DNA22, and VH11, members of the VH1 (J558)
and VH7 (S107) gene families. The important finding is that out of seven V gene
segments used by spontaneous anti-DNA antibodies, F(0.367) is only expressed by the
germline configuration of these three V gene segments. The data suggest that antibody
specificity for the phosphate group moiety delineated as F(0.367) is the intrinsic property
of the V germline gene segments used, whereas paratope/epitope interaction with
antigens bearing this epitope, such as PC or dsDNA, requires corresponding antibody
VH conformation that is susceptible to somatic mutation(s).
Keywords: anti-DNA antibodies, anti-PC antibodies, VH germline genes, Characterization of antibody specificity
by ISM, dsDNA reactive antibodies
INTRODUCTION
Natural autoantibodies, mainly IgM whose heavy chains are encoded by unmutated VDJ
genes, play a role in immune system homeostasis, provide the first line of defense
against infections, and may play a role in autoimmune disease as somatically mutated
IgG autoantibodies (1, 2). The highly diverse CDR3 loops are assumed as the key
determinant of specificity in antigen recognition, but in nonsomatically mutated antibodies,
binding sites may consist of germline-encoded CDR1 and CDR2 sequences dominating in
a number of contacts, whereas light chains play a subsidiary role to heavy chains (3,
4). It was also suggested that in contrast to antigen specificity determined by CDR3 (5),
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germline-encoded CDR1 and CDR2 sequences accommodate
binding to a number of different unrelated antigens (6). The
analyses also showed that despite the potential to generate almost
unlimited variability, the CDR regions exhibit a small number
of core main chain conformations termed “canonical structures”
(7). In particular, a limited repertoire of the main chain adopted
conformations dependent on the loop length and a few key
conserved residues at defined positions (8) has been assigned to
CDR1 and CDR2 regions (9).
One of the best studied primary antibody responses to
phosphocholine (PC) is T15 antibody expressing heavy and light
chain products of the T15(V1) and Vk22 germline genes in mice
(10–13). It is of interest that in ontogeny, T15 predominant
clonotypes appear about 1 week after birth (14), whereas PC-
specific responses or precursors were detected as early as 1
day after birth (15). An important finding is that the heavy
chains of T15 and other PC binding proteins bearing M603 and
M167 idiotypic determinants are derived from a single germline
T15(V1) gene segment and three light chains, i.e., T15 (VK22),
M603 (VK8), and M167 (VK24) (13, 16, 17).
Crystallography studies of the anti-PC binding antibody
provide evidence for the PC contact residues, revealing that
favorable interaction of the choline moiety is with CDR1 Glu-
35, whereas specific interactions occur between the phosphate
group and charged groups such as CDR2 Arg-52 that produce
a large favorable electrostatic interaction and Lys-54 that helps
neutralize the PC negative charge (18, 19). The data obtained
from mutagenesis experiments conferred importance of CDR2
Arg-52 as a site for interaction with the PC phosphate group (20),
whereas interaction with the carrier involves different sites (21).
The role of CDR2H52-H56motif in nucleic acid binding was also
demonstrated by analyses of monoclonal autoantibodies derived
from lupus-prone mice (22).
On the other hand, T15 CDR2 sequence VH50-60 region,
a part of the self-binding domain (homophilicity), enhances
antibody potency (23). The CDR2 of T15 antibody, according
to our view, may also have an immunoregulatory role in the
ontogeny of natural Tregs and consequently in the control of T15
and some anti-DNA antibody diversification (24).
Anti-DNA antibodies recognize a considerable number of
different epitopes, and their exact nature is only partially
known (25). Anti-dsDNA antibodies may react with linear and
conformational determinants exposed on the double helix of
DNA and cross-react with different antigens (26). For example,
a similar arrangement of phosphate groups in the DNA sugar-
phosphate backbone and phospholipids may explain cross-
reactivity (27).
Sequence analysis of anti-dsDNA antibodies from
autoimmune mice revealed a high frequency of mutations
and the presence of basic amino acids in the CDRs, such as
Arg and Lys and polar Asn with the potential to interact with
structures within dsDNA (28–31) or, when gained during
Abbreviations: CDR, Hypervariable region; CIS, Cross-spectral analysis; EIIP,
Electron-ion interaction potential; ISM, Informational spectrum method; IS,
Informational spectrum; RRM, Resonant recognition model; S/N, Signal-to-noise
ratio; VH, Variable heavy chain.
affinity maturation, be critical for CDR3 region interaction
with histone-DNA complex (32–34). This complex according
to a hapten-carrier-like model, may initiate production of both
anti-dsDNA and other anti-nucleosome antibodies [reviewed in
(35)].
In prior studies, we have shown that antibody VH domains
of anti-PC T15 and T15 dsDNA binding somatic mutant, U4
(13), encode characteristic sequence information represented
with F(0.367) (36). In this report, we extended this finding
by showing that F(0.367) is also expressed by several anti-
DNA antibody VH domains that use V germline or somatically
mutated S57(VH31), MRL-DNA22, and VH11 gene segments
of the VH1 (J558) and VH7 (S107) gene families, as well as
that protein sequences of these germline genes in addition
to T15(V1) encode an intrinsic epitope specificity represented
by F(0.367). Obtained data suggests that as long as the
frequency is expressed by an antibody VH domain (a) the
corresponding conformation for paratope/epitope interaction
might be preserved despite somatic mutations and (b) because
of somatic mutation(s), interaction with another antigen bearing
the same epitope might be achieved and vice versa, loss of the
characteristic frequency may cause achievement of a new epitope
specificity.
METHOD
The sequence analysis was performed by applying
the informational spectrum method (ISM). The
physicomathematical basis of ISM was described in detail
elsewhere (37), and here, we will only point the basic steps
involved by the method. According to the ISM approach, also
denoted as resonant recognition model (RRM) (38), protein
sequences are transformed into signals by assignment of
numerical values of each amino acid. These values correspond
to electron–ion interaction potential (39) determining electronic
properties of amino acids that are responsible for their
intermolecular interactions (40–43). The signal obtained is
decomposed in periodical function by Fourier transformation.
The result is a series of frequencies and their amplitudes
(the informational spectrum, IS). Detailed steps (43) that
precede obtaining the IS by the ISM are explained in
the Supplementary Information. The obtained frequencies
correspond to the distribution of structural motifs with defined
physicochemical characteristics determining the biological
function of the sequence. When comparing proteins that share
the same biological function, the technique allows detection of
code/frequency pairs in IS, which are specific for their common
biological properties. This common information is represented
by characteristic peaks in the cross-spectrum (CIS) of proteins.
The method is insensitive to the location of the motifs and,
thus, does not require the previous alignment of the sequence.
A measure of similarity for each peak is a signal-to-noise ratio
(S/N), which represents a ratio between signal intensity at
one particular IS frequency and the mean value of the whole
spectrum which depends on the number of the sequences used
in the analysis.
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RESULTS
Our previous data showed that VH domain of the anti-PC
T15 idiotype antibody that uses an unmutated copy of the V
germline gene T15(V1) (16, 17), as well as anti-PC binding
antibodies of different idiotypes, encode information represented
with F(0.367) in short F(0.37) (36). We also showed that F(0.37),
is independent of a single substitution-glutamic acid to alanine, at
position 35 in the T15 antibody CDR1 region, causing reactivity
acquisition for dsDNA (13) but depends on mutations in CDR2
region (36). In this report, seven V germline gene amino acid
sequences used by spontaneous anti-DNA antibodies (31) were
analyzed; of which, only three showed F(0.367) in individual
spectra such as S57(VH31) (30),MRL-DNA22 (44) germline gene
segments members of the VH1(J558) gene family, and VH11 (45)
member of the VH7(S107) gene family. The CIS of the T15(V1),
S57(VH31), MRL-DNA22, and VH11V germline gene segment
amino acid sequences is presented in Figure 1A, revealing a peak
at F(0.367). The T15(V1) V germline gene segment from the
VH7(S107) gene family is introduced because VH domains of
antibodies that express F(0.367), as we have shown previously
(36), use this V gene segment in germline configuration (13,
16, 17). The CIS of the four V germline gene segments used by
anti-DNA antibodies (31), such as BWDNA16, 2F2, BWDNA7,
and VH283, which do not express F(0.367) is presented in
Supplementary Table 1, revealing that characteristic peak is not
at F(0.367).
In this report, the analysis was performed on 60 spontaneous
anti-DNA VH domain sequences (31); of which, 20 are encoded
by the V gene segments that express F(0.367). However, F(0.367)
expression is limited, because only six antibody VH domains
retained this characteristic (30%). Thus, we found that F(0.367)
is expressed by IgG 74.c2 out of three individually analyzed VH
domains of anti-DNA antibodies that use VH11V gene segment
or by IgG 17s-c2 out of nine analyzed anti-DNA antibodies that
use S57(VH31) as well as IgG 17s.83, IgG 17s-c3, IgM 111.185,
and IgM 165.27 out of eight analyzed VH domains encoded by
MRL-DNA22V gene segment. The CIS of the VH domains of
these antibodies is shown in Figure 1B revealing a dominant
peak at F(0.367). It might be concluded that some anti-DNA
antibodies encoded by these V gene segments have lost F(0.367)
as the result of somatic mutations.
In Figure 1C, CIS of VH domains for 54 anti-DNA VH
domains is shown which, in an individual spectrum, does not
express F(0.367) and thus do not encode epitope specificity for
phosphate groups of dsDNA backbone. It should be emphasized
that a peak at F(0.023) with dominant S/N value is detected
for the V gene segments (Figure 1A), whereas it is a unique
peak in the CIS (Figure 1C) obtained for anti-DNA VH
domains, whose individual sequences do not express F(0.367)
a feature relevant for the specificity here analyzed. An analysis
of antibodies reactive with ssDNA, Z-DNA, and chromatin
further confirms the connection between F(0.367) expression and
antibody specificity for the phosphate group of B DNA backbone
as shown in Supplementary Figures 1B–D.
It is of interest to note that comparison of the V gene
segments and VH domain contribution to S/N value for the peak
at F(0.367) revealed an insignificant CDR3 region contribution
(Table 1).
We further made an attempt to determine peptide position
in the V gene segment sequences mostly contributing to the
F(0.367) expression. The data obtained showed that for T15(V1),
VH11(VH7), S57[VH31(VH1)], and MRL-DNA22(VH1) V
germline gene segments, these peptides involve residues at
positions 35–66, 36–67, 46–65, and 46–77, respectively. The most
important finding is that selected peptides include CDR2 regions
that are abundant in basic residues (Table 2), indicating an CDR2
role in both F(0.367) expression and interaction with an antigenic
determinant shared by the PC hapten and dsDNA.
The data obtained from the VH domains analysis of
two preimmune natural polyreactive autoantibodies, E7 and
D23 (46), which react with antigens such as DNA, myosin,
actin, tubulin, spectrin, and trinitrophenol, revealed that
F(0.367) was not expressed (Figure 1D), meaning that epitope
specificity of these antibodies differs from dsDNA-reactive anti-
DNA antibodies here analyzed. The CDR2 regions of these
autoantibodies are in germline configuration and with a reduced
number of basic residues.
DISCUSSION
Previously, using ISM for protein sequence analysis (37),
we showed that antibody VH domains of T15 PC binding
antibody and U4 dsDNA binding antibody encode information
determining sequence specificity represented with characteristic
frequency F(0.367), in short F(0.37) (36). We also showed that
this frequency is dependent on the type of residues in the CDR2
region and insensitive to a residue substitution in CDR1 (36)
of the T15 U4 mutant (13). In this report, we extend these
findings by showing that F(0.367) is not only expressed by VH
domains of T15 and some spontaneous anti-DNA antibodies
from autoimmune mice but is found to be also intrinsic for the
V germline gene segments used by these antibodies.
It has been shown that anti-PC binding antibody VH encoded
by T15(V1) V gene segment of the VH7(S107) germline gene
family (13, 16, 17) form strong interactions between the PC
phosphate group and charged residues in the CDR2 region, such
as Arg-52 and Lys-54, whereas CDR1 region Glu-35 is involved
in choline binding (17, 18). Therefore, F(0.367) expressed by
antibodies such as T15, T15 somatic mutant U4, and some anti-
DNA antibodies may characterize epitope specificity, that is,
specificity for phosphate groups present on different antigens
such as PC hapten and dsDNA. Furthermore, the data presented
showed that expression of the S/NF(0.367) mostly depends on
antibody V gene segments, and thus, a contribution of the CDR3
regions is insignificant (Table 1). It should be emphasized that
IgGV gene segments of anti-DNA antibodies expressing F(0.367)
can be close to germline configuration such as antibodies 74.c2
and 17s.83 encoded by the V gene segment VH11 of the VH7
(S107) gene family and MRL-DNA22 of the gene family VH1
(J558), respectively (31), suggesting that some mutations are
tolerable as they do not affect the specificity delineated by the
F(0.367). However, they differed in CDR3 regions (31), and their
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FIGURE 1 | ISM analysis of the V germline genes and antibody VH domain protein sequences. The CIS of the V germline genes segments of VH1, VH11, S57(VH31)
and MRL-DNA22 which shows characteristic F(0.367) relevant for the biological activity here followed and activity irrelevant F(0.023) (A). The CIS of the VH domains of
antibodies 74.c2 encoded by the V gene segment VH11, a member of the VH7 (S107) gene family, 17s-c2 encoded by the V gene segment S57(VH31) and 17s.83,
17s-c3, 111.185 and 165.27 encoded by V gene segment MRL-DNA22 of the VH1 (J558) gene family (B). CIS of all anti-DNA antibodies which in individual spectrum
does not express F(0.367) (C). The IS of the preimmune natural polyreactive autoantibodies which use V gene segments from VH2 (Q52) gene family such as D23 VH
domain (___) and superimposed IS of the E7 VH domain (…...) (D). The abscissa represents the frequencies from the Fourier transform of the sequence of electron-ion
interaction potential (EIIP). The lowest frequency is 0.0 and the highest is 0.5. The ordinate represents the signal to noise ratio (S/N) corresponding to each frequency
component in the informational spectrum (IS).
TABLE 1 | Contribution of antibody VH domains and corresponding V gene segments to S/NF(0.367).
Antibodies Antibody isotype V germline gene segment used VH gene family S/NF(0.367)
Domains V gene segments
T15 IgG T15(V1) VH7 (S107)* 3.727 3.544
U4 IgG T15(V1) VH7 (S107)* 3.950 3.821
74.c2 IgG VH11 VH7 (S107)* 5.622 5.304
17s-c2 IgG S57(VH31) VH1 (J558)* 4.148 4.008
17s.83 IgG DNA22 VH1 (J558)* 3.789 3.383
17s-c3 IgG DNA22 VH1 (J558)* 4.434 3.944
111.185 IgM DNA22 VH1 (J558)* 3.963 3.623
165.27 IgM DNA22 VH1 (J558)* 3.731 3.259
*Old nomenclature for VH gene families is given in parenthesis.
contribution to F(0.367) expression is insignificant (Table 1),
whereas IgM 111.185 (MRL-DNA22) anti-DNA antibody (31)
retains V gene segment in germline configuration. The data
presented may be in accord with the idea that V germline
gene segments prone to bind a dsDNA epitope should be less
dependent on CDR3 regions (48).
Anti-dsDNA antibodies derived from autoimmune mouse
models revealed that they have undergone somatic mutations
suggesting their role in achievement of the corresponding
conformation. Thus, an important finding obtained from
sequence analysis showed the presence of basic amino acids Arg,
Lys, and His and, perhaps, the uncharged Asn in CDRs (28–31),
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TABLE 2 | Sequence alignment for CDR2 regions of the V gene segments.
V gene segments Germline configuration Antibody CDR2 region amino acid sequence
abc
MRL-DNA22 + N I Y P G S S S T N Y N E K F K S
MRL-DNA22 111.185 – – – – – – – – – – – – – – – – –
MRL-DNA22 165.27 – – – – – – – – – – – – – – – – –
MRL-DNA22 17s.83 N – – – – – I I – H F N – K – K N
MRL-DNA22 17s-c3 E – – – R – G N I Y Y N – K – K G
abc
S57(VH31) + W I Y S G S G N T K Y N E K F K D
S57(VH31) 17s-c2 – – – P – – – N – K – N – K – K –
VH11 + L I R N K A N G Y T T E Y S A S V K G
VH11 74-c2 – – R N K – N D – – – – – – – – – K –
a b c
T15(V1) + A S R N K A N D Y T T E Y S A S V K G
T15(V1) T15 – – R N K – N – – – – – – – – – – K –
T15(V1) U4 – – R N K – N – – – – – – – – – – K –
VH1210.7 + Y I S Y S G S T Y Y N P S L K S
VH1210.7 E7 – – – – – – – – – – – – – – – –
VH101 + V I W S G G S T D Y N A A F I S
VH101 D23 – – – – – – – – – – – – – – – –
The CDR2 region sequences (aa 50-65) for V germline genes and epitope specific anti-DNA antibodies shown in the single letter code were taken from Tillman et al. (31). Origin of these
V germline gene sequences are: S57(VH31) (30), MRL-DNA22 (44), VH11 (45). Sequences for T15(V1), as well as E7 and D23 antibodies are taken from Diamond and Scharff (13),
Crews et al. (16), Rudikoff et al. (17), and Baccala et al. (46) respectively. Within the compared antibody V gene segments dashes indicate identity with the reference germline gene
sequences, while basic residues are shown in bold. Numbering is according to Kabat et al. (47).
whereas Arg in the CDR3 has an important contribution in
DNA specificity for DNA-histone complexes (32–34). However,
cationic amino acids were not necessary for immune deposit
formation (49). Thus, another goal of this study was to examine
the role of the CDR2 regions in F(0.367) expression and in
particular the content of basic residues in the CDR2 regions of V
germline genes used by anti-DNA antibodies. The data obtained
showed that peptides within sequences mostly contributing to
F(0.367) expression cover residues at position 35–66 for T15(V1),
36–67 for VH11, 46–65 for S57(VH31), and 46–77 for MRL-
DNA22. It should be emphasized that these peptide sequences
include the CDR2 region enriched in basic residues of T15(V1),
VH11, S57(VH31), and MRL-DNA22 germline genes and are
also present in CDR2 regions of antibody VH domains (Table 2).
It can be seen that type and positions of the basic residues
for CDR2 of the T15(V1) and VH11V germline gene segments
and anti-DNA antibody V gene segments are the same and
S57(VH31) differs slightly. The MRL-DNA22 anti-DNA IgM
isotypes are close to germline configuration, whereas IgG differs
in the type and position of basic residues (Table 2). The CDR2
regions of natural polyreactive autoantibodies are in germline
configuration and have one or two basic residues, confirming that
both the number and position in CDR2 regions are important for
antibody epitope specificity.
The findings presented indicate that antibody specificity for
an antigenic determinant (epitope) in the context of different
antigens might be identified by the ISM approach (37).
The method applied made a possible correlation between
primary antibody structure and specificity delineated by a
characteristic frequency.
The main conclusion is that antibody VH domain sequences
can encode ability expressed as characteristic frequency, to
interact with non-protein structures of various molecules after
achievement of the corresponding conformation by somatic
mutations.
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